205 related articles for article (PubMed ID: 30471828)
1. Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancer.
Xiao X; Xu M; Yang C; Yao Y; Liang LN; Ed Chung P; Long Q; Zacksenhaus E; He Z; Liu S; Ben-David Y
Bioorg Med Chem; 2018 Dec; 26(23-24):6096-6104. PubMed ID: 30471828
[TBL] [Abstract][Full Text] [Related]
2. One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells.
Eldehna WM; El-Naggar DH; Hamed AR; Ibrahim HS; Ghabbour HA; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):309-318. PubMed ID: 29281924
[TBL] [Abstract][Full Text] [Related]
3. Indole-2-Carboxamide Derivative LG25 Inhibits Triple-Negative Breast Cancer Growth By Suppressing Akt/mTOR/NF-κB Signalling Pathway.
Xu X; Rajamanickam V; Shu S; Liu Z; Yan T; He J; Liu Z; Guo G; Liang G; Wang Y
Drug Des Devel Ther; 2019; 13():3539-3550. PubMed ID: 31631978
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and identification of novel indolo[2,3-a]pyrimido[5,4-c]carbazoles as a new class of anti-cancer agents.
Pierce LT; Cahill MM; Winfield HJ; McCarthy FO
Eur J Med Chem; 2012 Oct; 56():292-300. PubMed ID: 22910137
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Anti-Cancer and Anti-Migratory Evaluation of 3,6-Dibromocarbazole and 5-Bromoindole Derivatives.
Butler-Fernández KM; Ramos Z; Francis-Malavé AM; Bloom J; Dharmawardhane S; Hernández E
Molecules; 2019 Jul; 24(15):. PubMed ID: 31344865
[TBL] [Abstract][Full Text] [Related]
6. Discovering alkylamide derivatives of bexarotene as new therapeutic agents against triple-negative breast cancer.
Chen L; Long C; Nguyen J; Kumar D; Lee J
Bioorg Med Chem Lett; 2018 Feb; 28(3):420-424. PubMed ID: 29287960
[TBL] [Abstract][Full Text] [Related]
7. Sophoridine Derivatives Induce Apoptosis and Autophagy to Suppress the Growth of Triple-Negative Breast Cancer through Inhibition of mTOR Signaling.
Dai L; Wang L; Tan C; Cai J; Shen H; Zhang T; Zhi S; Yang Z; Hu Y; Zhao X; Li D
ChemMedChem; 2022 Jan; 17(1):e202100434. PubMed ID: 34569159
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
9. Novel 5-azaindolocarbazoles as cytotoxic agents and Chk1 inhibitors.
Lefoix M; Coudert G; Routier S; Pfeiffer B; Caignard DH; Hickman J; Pierré A; Golsteyn RM; Léonce S; Bossard C; Mérour JY
Bioorg Med Chem; 2008 May; 16(9):5303-21. PubMed ID: 18342518
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel pyrano[3,2-c]carbazole derivatives as anti-tumor agents inducing apoptosis via tubulin polymerization inhibition.
Padmaja P; Koteswara Rao G; Indrasena A; Subba Reddy BV; Patel N; Shaik AB; Reddy N; Dubey PK; Bhadra MP
Org Biomol Chem; 2015 Feb; 13(5):1404-14. PubMed ID: 25467166
[TBL] [Abstract][Full Text] [Related]
11. Construction of Benzo[c]carbazoles and Their Antitumor Derivatives through the Diels-Alder Reaction of 2-Alkenylindoles and Arynes.
Sha F; Tao Y; Tang CY; Zhang F; Wu XY
J Org Chem; 2015 Aug; 80(16):8122-33. PubMed ID: 26204058
[TBL] [Abstract][Full Text] [Related]
12. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of pyranocarbazole derivatives as Anti-tumor agents.
Liu K; Zang Y; Shen C; Li C; Ma J; Yang J; Sun X; Chen X; Wang N; Zhang D
Bioorg Med Chem Lett; 2021 Feb; 33():127739. PubMed ID: 33316408
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel pyrrolo[2,3-a]carbazoles: 7-Chloro-2-oxo-3a-(2'-oxo-2',3'-dihydro-1'H-indol-3'-yl)-2,3,3a,4,5,10-hexahydro-pyrrolo[3,2-a]carbazole-1-carbonitrile as an efficient anticancer agent.
Sathiyachandran P; Manogaran P; Nesterov VN; Padma VV; Rajendra Prasad KJ
Eur J Med Chem; 2018 Apr; 150():851-863. PubMed ID: 29597168
[TBL] [Abstract][Full Text] [Related]
15. Biological potential of carbazole derivatives.
Głuszyńska A
Eur J Med Chem; 2015 Apr; 94():405-26. PubMed ID: 25794500
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of substituted 11H-benzo[a]carbazole-5-carboxamides as novel antitumor agents.
Wang YQ; Li XH; He Q; Chen Y; Xie YY; Ding J; Miao ZH; Yang CH
Eur J Med Chem; 2011 Dec; 46(12):5878-84. PubMed ID: 22000922
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and structure-activity relationship studies of a focused library of pyrimidine moiety with anti-proliferative and anti-metastasis activities in triple negative breast cancer.
Yao D; Zhou Y; Zhu L; Ouyang L; Zhang J; Jiang Y; Zhao Y; Sun D; Yang S; Yu Y; Wang J
Eur J Med Chem; 2017 Nov; 140():155-171. PubMed ID: 28923383
[TBL] [Abstract][Full Text] [Related]
18. An allomaltol derivative triggers distinct death pathways in luminal a and triple-negative breast cancer subtypes.
Ercan A; Oncul S; Karakaya G; Aytemir M
Bioorg Chem; 2020 Dec; 105():104403. PubMed ID: 33166845
[TBL] [Abstract][Full Text] [Related]
19. One-pot mild and efficient synthesis of [1,3]thiazino[3,2-a]indol-4-ones and their anti-proliferative activity.
Rhodes S; Short S; Sharma S; Kaur R; Jha M
Org Biomol Chem; 2019 Apr; 17(16):3914-3920. PubMed ID: 30942251
[TBL] [Abstract][Full Text] [Related]
20. An autophagy-dependent cell death of MDA-MB-231 cells triggered by a novel Rhein derivative 4F.
Liu Y; Zhong Y; Tian W; Lan F; Kang J; Pang H; Hou H; Li D
Anticancer Drugs; 2019 Nov; 30(10):1038-1047. PubMed ID: 31274517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]